Just thought I'd make you all aware of this:
The MHRA are proposing to restrict the availability of medicines
containing pseudoephedrine and ephedrine by a change to legal status from Pharmacy (P) to prescription only (POM), together with a restriction in pack size in the UK in the light of reports of misuse of these substances in the manufacture of the Class A controlled drug methylamphetamine. A legal status change may be effected by an amendment to the Prescription Only Medicines (Human Use) Order 1997 (the POM Order) or by changing the legal status on the marketing authorisations (MAs).
What do you all think of this?
An over-reaction? (Exactly how many reports of meth manufacture have there been compared with total pseudoephedrine sales?)
Or protecting public safety?
You can feedback to the MHRA here: Feedback to current consultation documents
The MHRA are proposing to restrict the availability of medicines
containing pseudoephedrine and ephedrine by a change to legal status from Pharmacy (P) to prescription only (POM), together with a restriction in pack size in the UK in the light of reports of misuse of these substances in the manufacture of the Class A controlled drug methylamphetamine. A legal status change may be effected by an amendment to the Prescription Only Medicines (Human Use) Order 1997 (the POM Order) or by changing the legal status on the marketing authorisations (MAs).
What do you all think of this?
An over-reaction? (Exactly how many reports of meth manufacture have there been compared with total pseudoephedrine sales?)
Or protecting public safety?
You can feedback to the MHRA here: Feedback to current consultation documents
Comment